Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kampf

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Pharmakopsychiatrie, Neuro-Psychopharmakologie|July 1, 1980
Renal function and biopsy in patients on lithium-therapyJ Albrecht, D Kampf, B Müller-Oerlinghausen
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of mepindolol in patients with chronic renal failureW Krause, D Kampf, H C Fischer
Der Nervenarzt|February 1, 1981
[Lithium prophylaxis and renal function. Conclusions and guidelines for treatment control (author's transl)]B Müller-Oerlinghausen, J Albrecht, D Kampf
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patientsD Kampf, K Borner, H Hain, et al.
Medizinische Klinik|September 9, 1977
[Renal vein thrombosis: a complication of the nephrotic syndrome? (author's transl)]D Kampf, H Becker, W Höfer, et al.
Clinical Nephrology|January 1, 1983
Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal functionD Kampf, R Schurig, A Bergs, et al.
Archives of Dermatological Research|May 4, 1979
HLA-antigens in systemic lupus erythematosus (SLE)D Kampf, R Malchus, M Alexander, et al.
Immunitat Und Infektion|August 1, 1979
[Clinico-pathological correlations in lupus nephritis with reference to therapeutic and prognostic aspects (author's transl)]D Kampf, W Höfer, V Misgeld, et al.
Intensive Care Medicine|March 2, 1999
Severe panarteritis associated with drug abuseM Möckel, D Kampf, H Lobeck, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal functionD Kampf, K Borner, M Möller, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Pharmakopsychiatrie, Neuro-Psychopharmakologie|July 1, 1980
Renal function and biopsy in patients on lithium-therapyJ Albrecht, D Kampf, B Müller-Oerlinghausen
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of mepindolol in patients with chronic renal failureW Krause, D Kampf, H C Fischer
Der Nervenarzt|February 1, 1981
[Lithium prophylaxis and renal function. Conclusions and guidelines for treatment control (author's transl)]B Müller-Oerlinghausen, J Albrecht, D Kampf
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patientsD Kampf, K Borner, H Hain, et al.
Medizinische Klinik|September 9, 1977
[Renal vein thrombosis: a complication of the nephrotic syndrome? (author's transl)]D Kampf, H Becker, W Höfer, et al.
Clinical Nephrology|January 1, 1983
Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal functionD Kampf, R Schurig, A Bergs, et al.
Archives of Dermatological Research|May 4, 1979
HLA-antigens in systemic lupus erythematosus (SLE)D Kampf, R Malchus, M Alexander, et al.
Immunitat Und Infektion|August 1, 1979
[Clinico-pathological correlations in lupus nephritis with reference to therapeutic and prognostic aspects (author's transl)]D Kampf, W Höfer, V Misgeld, et al.
Intensive Care Medicine|March 2, 1999
Severe panarteritis associated with drug abuseM Möckel, D Kampf, H Lobeck, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal functionD Kampf, K Borner, M Möller, et al.
Pageof 7